Save 20% on Your First Cell Line-Derived Xenograft (CDX) Study With BioDuro
We invite new clients to conduct a CDX study with BioDuro Oncology, backed by 13 years of CRO experience in oncology and drug discovery, with a special introductory 20% discount.
300+ Cancer Cell Lines and 80 Validated CDX Models
Well-established and widely used models for preclinical testing of anti-cancer drug efficacy
Subcutaneous, Orthotopic and Experimental Metastatic Models
Intravenous, subcutaneous or orthotopic implantation into immunodeficient mice
32 Luciferase Labeled Cell Lines and In Vivo Models
Non-invasive tools for studying disease progression
In Vivo Bioluminescent and Fluorescent Imaging
Increased robustness, signal-to-noise ratio and faster kinetics
Enroll and Save on a CDX Study Today!
Explore how we can meet your preclinical oncology research needs, contact us directly.
Advance efficacy studies of your novel agents today
20% discount for new clients is available through December 31, 2018
Terms and Conditions: Offer valid through December 31, 2018. Offer may not be applied to existing, pending or previous orders. Offer cannot be combined with any additional discounts or promotions. We reserve the right to change the terms and conditions of this promotion without notice.